Stable Isotope Labeled Compounds Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 3.3 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The Stable Isotope Labeled Compounds market is projected to grow with a CAGR of nearly 3.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of cancer. According to the National Institutes of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. Furthermore, the growing investments in research and development programs by the biotechnology and pharmaceutical companies is boosting the market growth. However, the high cost of the isotope compounds is the major drawback of the market.
Scope of the Report
As per the scope of the report, stable isotopes are non-radioactive forms of atoms. Although they do not emit radiation. This report is segmented by Type, by Application, and by Geography.
| By Type | |
| Deuterium | |
| Carbon-13 | |
| Oxygen-18 | |
| Other Stable Isotopes |
| By Application | |
| Research and Development | |
| Clinical Diagnostics | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Research and Development Segment is Dominating the Stable Isotope Labeled Compounds Market.
The growth of the segment is attributed to the increase in research and development spending. Both government and major players are investing in product development. Stable isotope tracers can be safely governed simultaneously to the same subject without compromising future studies. The plasma volume which is needed from one sample to analyze the isotope enrichment is small, allowing even preterm infants to be studied. Extensive studies are going on for biological side effects and metabolic fate of the compound. The other factors that are boosting the market growth are the increasing incidence of cancer as these are majorly used in cancer diagnostics.
To understand key trends, Download Sample Report
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of cancer in the region, established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.
To understand geography trends, Download Sample Report
Competitive Landscape
The Stable Isotope Labeled Compounds market is moderately competitive and consists of several major players. Some of the international companies that are present in this market are PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, Alsachim, Taiyo Nippon Sanso Corporation.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Proteomics Research
-
4.2.2 Rising Prevalence of Cancer
-
-
4.3 Market Restraints
-
4.3.1 Lack of Skilled Labour
-
4.3.2 High Cost of Stable Isotope-Labeled Compounds
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Deuterium
-
5.1.2 Carbon-13
-
5.1.3 Oxygen-18
-
5.1.4 Other Stable Isotopes
-
-
5.2 By Application
-
5.2.1 Research and Development
-
5.2.2 Clinical Diagnostics
-
5.2.3 Other Applications
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 PerkinElmer Inc
-
6.1.2 Merck KGaA
-
6.1.3 Cambridge Isotope Laboratories, Inc.
-
6.1.4 JSC Isotope.
-
6.1.5 Medical Isotopes, Inc.
-
6.1.6 Omicron Biochemicals, Inc.
-
6.1.7 Trace Sciences International
-
6.1.8 Alsachim
-
6.1.9 Taiyo Nippon Sanso Corporation
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Stable Isotope Labeled Compounds Market market is studied from 2018 - 2026.
What is the growth rate of Stable Isotope Labeled Compounds Market?
The Stable Isotope Labeled Compounds Market is growing at a CAGR of 3.3% over the next 5 years.
Which region has highest growth rate in Stable Isotope Labeled Compounds Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Stable Isotope Labeled Compounds Market?
North America holds highest share in 2021.
Who are the key players in Stable Isotope Labeled Compounds Market?
PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope., Medical Isotopes, Inc. are the major companies operating in Stable Isotope Labeled Compounds Market.
